Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01563159|
Recruitment Status : Completed
First Posted : March 26, 2012
Last Update Posted : March 14, 2018
|Condition or disease||Intervention/treatment|
|Infections, Rotavirus||Other: Data collection|
|Study Type :||Observational|
|Actual Enrollment :||1 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||Assessing the Rotavirus Positive Test Results in 11 Hospitals in Belgium From 2005 to 2013: the RotaBIS Study (Rotavirus Belgian Impact Study)|
|Actual Study Start Date :||March 31, 2015|
|Actual Primary Completion Date :||December 31, 2017|
|Actual Study Completion Date :||December 31, 2017|
All children ≤ 5 years old with a rotavirus detection test (inpatient and ambulatory tests) performed during the period of June the 1st 2010 and May the 31st 2011.
Other: Data collection
Each participating centre will be requested to generate a coded list of all stool samples taken during the study period (June 1st 2010- May 31st 2011) and analysed for rotavirus, in children aged ≤5 years.
- Absolute number of rotavirus related hospitalisations in children up to five years old. [ Time Frame: During the study period (from June 1st 2010 to May 31st 2011, i.e. up to 1 year) ]
- Proportion of rotavirus positive tests on the total number of rota detection tests [ Time Frame: During the study period (from June 1st 2010 to May 31st 2011, i.e. up to 1 year) ]Total number of rota detection tests and number of rotavirus positive tests of the study year will be determined by age-group of 1-year, gender, time of the event, vaccine coverage status.
- The duration of rota-related hospitalisation for community acquired and nosocomial infection. [ Time Frame: During the study period (from June 1st 2010 to May 31st 2011, i.e. up to 1 year) ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01563159
|Study Director:||GSK Clinical Trials||GlaxoSmithKline|